Nevro Corp
(NYSE:NVRO)
$
5.06
-0.26 (-4.89%)
Market Cap: 188.65 Mil
Enterprise Value: 166.94 Mil
PE Ratio: 0
PB Ratio: 0.69
GF Score: 42/100 Nevro Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023 / 03:30PM GMT
Release Date Price:
$27.78
(+0.80%)
Shagun Singh
RBC Capital Markets - Analyst
Welcome to the 2023 RBC Global Healthcare Conference. I'm Shagun Singh, senior medical device analyst at RBC. And I'm very pleased to have our next company here with us, Nevro. Joining us from the company are Rod MacLeod, Chief Financial Officer; as well as Julie Dewey, Chief Corporate Communications and Investor Relations Officer.
Rod and Julie, thank you so much for being here today. We really appreciate it.
Rod MacLeod
Nevro Corp. - SVP & CFO
Thanks for having us.
Julie Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer
Thank you.
Questions & Answers
Shagun Singh;
RBC Capital Markets - Analyst
Great. So I thought we'll kick it off with Q1 2023 results and guidance since you just reported, maybe starting with procedure volumes. Can you perhaps give us some color on monthly trends that you saw in Q1 as well as any color quarter-to-date that you may be seeing in Q2?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot